肝功能障碍和通过毒性的神经精神病学后果
Kang Woo Kim1, Manish Shrestha2,3
1Department of internal Medicine Rhode Island Hospital.
Journal of Brown hospital medicine
|October 6, 2025
概括
神经毒性可能会在肝病患者中引起混乱,甚至在运动症状出现之前. 早期识别是管理肝脏脑病和积累的关键.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 是一种必不可少的微量元素,对许多生理过程至关重要.
- 然而,含量升高或排泄受损可能导致的神经毒性.
- 慢性肝病会影响身体消除的能力,增加风险.
研究的目的:
- 报告一个神经毒性病例,呈现神经精神症状,先前是运动缺陷.
- 突出诊断方面的挑战,以及在肝功能障碍患者中考虑毒性的重要性.
主要方法:
- 一个50岁的慢性肝病患者的病例报告.
- 临床评估包括神经学检查和认知评估.
- 大脑的磁共振成像 (MRI) 检测T1超强度在地球上.
主要成果:
- 患者呈现出恶化的困惑,神经精神病症状.
- 大脑MRI揭示了T1超强度在白球,表明积累.
- 帕金森运动特征在演示时显著缺席.
结论:
- 这种情况表明神经毒性的双相呈现,神经精神症状可以在运动缺陷之前出现.
- 在患有慢性肝病的患者中,应考虑的神经毒性,这些患者经历了无法解释的神经精神疾病的变化.
- 及时识别和管理对于预防不可逆转的神经损伤至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
253
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
253
Disorders of the Nervous Tissue
2.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.5K
Vitamins
2.3K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


